Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Colombier Acquisition Corp. is a type of financial asset known as a special purpose acquisition company (SPAC). The primary purpose of such a company is to raise capital through an initial public offering (IPO) with the intent of acquiring or merging with an existing private company. This allows the target company to go public without undergoing the traditional IPO process. Colombier Acquisition Corp. provides a strategic vehicle for taking promising private innovations to public markets, offering them access to increased liquidity and capital for expansion. SPACs like Colombier are significant in the financial market as they create opportunities for investors to participate in private companies' growth without the complexities of direct investment. They often focus on specific industries, seeking out businesses that demonstrate potential for substantial growth and return on investment. Colombier Acquisition Corp.'s formation and operations play a crucial role in facilitating entrepreneurial ventures, thereby impacting sectors ranging from technology and healthcare to consumer goods and industrials.
$10.26
+$0.00 (+0.00%)
EOD Aug 13, 2026
At 52x earnings, the current multiple leaves limited room for execution misses or growth deceleration. Negative free cash flow of -$2M. The business is consuming cash, not generating it.
52.0x earnings. The market is pricing in years of above-average growth. If that thesis breaks, downside from multiple compression alone could be 30%+. This is a stock where you're paying for the future, not the present.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$0.00
Net Income (TTM)
$4M
Op. Margin
—
ROIC
-1.39%
Cash Flow & Balance Sheet
FCF (TTM)
-$2M
Op. Cash Flow (TTM)
-$2M
Net Debt
-$905K
Net Cash Position
Cash & Equiv.
$905K
Continue Research
At a P/E of 52.0, Colombier Acquisition (CLBR)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Colombier Acquisition scores 14/100 on Intrinsiqq's quality scorecard, weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Colombier Acquisition scores 14 out of 100 on Intrinsiqq's quality score, a weighted blend of 4 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -1.4% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh CLBR's valuation and scores 14/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.